₹919.5015.651.73%(1D)
Performance Stats for Zydus Lifesciences
Day Range
Low: ₹902.10
High: ₹920.80
52 Week Range
Low: ₹795.00
High: ₹1059.05
Open Price
903.50Previous Close
903.85Volume
510226.00Open Price
903.50Previous Close
903.85Volume
510226.00Fundamentals of Zydus Lifesciences
ROCE
30.47%
EPS
₹46.69
Dividend Yield
1.24%
P/E Ratio
15.43
P/B Ratio
4.2
Debt to Equity
0.39
Current Ratio
1.76
Sales Growth
8.38%
Profit Growth
6.53%
EBIT Growth
10.20%
Financials of Zydus Lifesciences
All values in Rs. Cr
All values in Rs. Cr
All values in Rs. Cr
Share Holding Pattern of Zydus Lifesciences
About Zydus Lifesciences
Zydus Lifesciences Limited, initially known as Cadila Healthcare Limited was incorporated in May, 1995, which changed to Zydus Lifesciences Limited on February 24, 2022. The Company is one of the leading innovation driven pharmaceutical companies in ...
Read more
Similar Sector Stocks
| Stocks | CMP |
| Alembic Pharma | ₹743.45 0.99% |
| Aurobindo Pharma | ₹1214.8 4.33% |
| Cipla | ₹1344.3 1.33% |
| Glenmark Pharmaceuticals | ₹2085.5 1.31% |
Most Viewed Stocks
Open Interest (OI)
Zydus Lifesciences Options
| Price | OI | Volume |
Events Related to Zydus Lifesciences
Board Meeting
Feb 9, 2026
Board Meeting
Nov 6, 2025
Board Meeting
Aug 12, 2025
AGM
Aug 12, 2025
Dividend
Jul 25, 2025
News About Zydus Lifesciences
Zydus Lifesciences in focus after USFDA clears Ahmedabad plant, Aflibercept biosimilar launch
Feb 20, 2026
Stocks To Watch Today: Cochin Shipyard, HUL, BEL, Zydus Lifesciences, Bharat Forge
Feb 19, 2026
Zydus Lifesciences among 5 midcap stocks showing bullish RSI upswing
Feb 13, 2026
Five Stocks To Buy: BEL, Tata Steel, Bajaj Finance And More | February 13, 2026
Feb 13, 2026
Zydus Lifesciences To Pay $120 Million To Astellas To Settle Patent Litigation
Feb 12, 2026
